News & Events

A team consisting of Hassan Lemjabbar-Alaoui, Ph.D., Assistant Adjunct Professor of Surgery and principal Investigator in the Thoracic Oncology Laboratory and Alaoui Lab, and Steven Rosen, PhD, Professor and Vice-chair of the Department of Anatomy, are developing a novel treatment for lung cancer in a unique...

Edward Kim, M.D. and Pierre R. Theodore, M.D. will be among the recipients of 2011 Haile T. Debas Academy of Medical Educator's Excellence in Teaching Awards at the Academy's annual Celebration on Monday, September 19, 2011. The Haile T. Debas Academy of Medical Educators is dedicated to creating an environment...

Thierry Jahan, M.D., an Associate Professor of Medicine Bonnie J. and Anthony Addario Endowed Chair in Thoracic Oncology, is one of four recipients of the 2010 UCSF Medical Center Exceptional Physician Award, an honor recognizing dedication to outstanding patient care and to the instiutions' values of...

Last October, opera singer Zheng Cao fell during a performance and had no idea why. Later, it turned out she had advanced lung cancer. Now, as a result of treatment with a new type of targeted therapy, her cancer is retreating. Personalized medicine - that is, customizing the treatment to the patient's tumor -is...

Dr. Jasleen Kukreja "is not the first surgeon to perform a minimally invasive lobectomy at UCSF, but she may be a pioneer in the two-finger clamp technique, because her predecessors are men who have a tougher time squeezing in both fingers. Last summer, she became the first doctor to be hired by UCSF to focus...

Before an overflow crowd at the UCSF Comprehensive Cancer Center, members of the Thoracic Oncology Program speak about the challenges of lung cancer and the progress that has been made in finding effective treatments and one day a cure.

Adding their own contributions to a rapidly advancing field, UCSF researchers - along with colleagues from Incyte Corporation and the University of Texas Southwestern Medical Center - have described new targets in lung cancer and evaluated a promising new drug candidate that halts growth signals in tumor cells...